C17H19FN2O2
302.34 g/mol
APIDanger
Safinamide
CAS133865-89-1EC603-772-2
Category
API
Compound Class
Amide
Primary Use
Pharmaceutical Raw Material
Safinamide is a pharmaceutical raw material used in the manufacturing of medications for Parkinson's disease. It functions as a selective inhibitor of monoamine oxidase B, contributing to the management of motor symptoms.
active pharmaceutical ingredient for Parkinson's disease medicationsmonoamine oxidase B inhibitor in pharmaceutical formulations
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 133865-89-1
Related Compounds
StrongSame Parent
Safinamide mesylate
CAS202825-46-5
pharmaceutical raw material
ReferenceSame Category
Valnemulin hydrochloride
CAS133868-46-9
pharmaceutical raw material
ReferenceSame Category
Aristolactam I
CAS13395-02-3
pharmaceutical raw material
ReferenceSame Category
5-methyltetrahydrofolic acid
CAS134-35-0
pharmaceutical raw material
ReferenceSame Category
Erythromycin propionate
CAS134-36-1
pharmaceutical raw material
Safety Reference
Danger
H301Toxic if swallowed
H318Causes serious eye damage
H400Very toxic to aquatic life
Identifiers
IUPAC Name
(2S)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide
InChIKey
NEMGRZFTLSKBAP-LBPRGKRZSA-N
SMILES
C[C@@H](C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F
Synonyms (21)
- Safinamide (USAN/INN)
- Safinamida
- Safinamide
- Safinamide (Standard)
- Xadago
- fbap methanesulfonate
- safinamidum